{"id":"NCT01263483","sponsor":"Takeda","briefTitle":"Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan","officialTitle":"A Phase 2/3, Double-blind, Randomized, Placebo-controlled, Parallel-group, Multicenter Study to Determine the Efficacy and Safety of SYR-322 When Used in Combination With α-glucosidase Inhibitor in Subjects With Type 2 Diabetes in Japan","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2007-01","primaryCompletion":"2008-04","completion":"2008-04","firstPosted":"2010-12-20","resultsPosted":"2011-07-11","lastUpdate":"2012-02-03"},"enrollment":230,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Alogliptin and voglibose","otherNames":["SYR-322","BASEN®","Voglibose"]},{"type":"DRUG","name":"Alogliptin and voglibose","otherNames":["SYR-322","BASEN®","Voglibose"]},{"type":"DRUG","name":"Voglibose","otherNames":["BASEN®"]}],"arms":[{"label":"Voglibose 0.2 mg TID","type":"ACTIVE_COMPARATOR"},{"label":"Alogliptin 12.5 mg QD and Voglibose 0.2 mg TID","type":"EXPERIMENTAL"},{"label":"Alogliptin 25 mg QD and Voglibose 0.2 mg TID","type":"EXPERIMENTAL"}],"summary":"The purpose of this study was to evaluate the efficacy and safety of alogliptin, once daily (QD) combined with an α-glucosidase inhibitor taken three times daily (TID) in type 2 diabetic patients with uncontrolled blood glucose.","primaryOutcome":{"measure":"Change From Baseline in Glycosylated Hemoglobin (Week 12).","timeFrame":"Baseline and Week 12.","effectByArm":[{"arm":"Voglibose 0.2 mg TID","deltaMin":0.04,"sd":0.457},{"arm":"Alogliptin 12.5 mg QD","deltaMin":-0.96,"sd":0.553},{"arm":"Alogliptin 25 mg QD and Voglibose 0.2 mg TID","deltaMin":-0.91,"sd":0.485}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":"33 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":1},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["22106975"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":75},"commonTop":["Nasopharyngitis","Eczema"]}}